Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry

Journal of Rheumatology

Volumn 40, Issue 1, 2013, Pages 74-79

  Zannin, Maria E ^a   Birolo, Carolina ^a   Gerloni, Valeria M ^b   Miserocchi, Elisabetta ^b   Pontikaki, Irene ^b   Paroli, Maria P ^d   Bracaglia, Claudia ^c   Shardlow, Alison ^e   Parentin, Fulvio ^e   Cimaz, Rolando ^f   Simonini, Gabriele ^f   Falcini, Fernanda ^g   Corona, Fabrizia ^h   Viola, Stefania ⁱ   De Marco, Riccardo ⁱ   Breda, Luciana ^j   La Torre, Francesco ^k   Vittadello, Fabio ^a   Martini, Giorgia ^a   Zulian, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁱ G GASLINI INSTITUTE   (Italy)

^j University of Chieti (University Hospital)   (Italy)

^k UNIVERSITY OF MESSINA   (Italy)

more..

Author keywords

Anti tumor necrosis factor agents; Juvenile idiopathic arthritis; Treatment; Uveitis

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; MYDRIATIC AGENT; PREDNISONE;

ARTICLE; CATARACT; CHILD; DISEASE COURSE; DISEASE DURATION; DISEASE REGISTRY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; INTRAOCULAR HYPERTENSION; IRIDOCYCLITIS; IRRITABILITY; ITALY; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MENSTRUATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; REMISSION; RETINA MACULA CYSTOID EDEMA; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; ITALY; MALE; REGISTRIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 84871873566     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120583     Document Type: Article

References (23)

1. Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis associated uveitis: Incidence of ocular complications and visual acuity loss. Am J Ophthalmol 2007;143:647-55.
2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2. (Pubitemid 38160763)
3. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Result of the First International Workshop. J Ophthalmol 2005;140:509-16. (Pubitemid 41224845)
4. Kotaniemi K, Sihto-Kauppi K. Occurrence and management of ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis: An observational series of 104 patients. Clin Ophthalmol 2007;1:455-9.
5. Rosenblum H, Amital H. Anti-TNF therapy: Safety aspects of taking the risk. Autoimmun Rev 2011;10:563-8.
6. Kump LI, Castaneda RA, Andreoudi SN, Reed GF, Foster CS. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology 2006;113:1874-7. (Pubitemid 44442436)
7. Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology 2006;45:982-9. (Pubitemid 44283053)
8. Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2007;143:647-55.
9. Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and long-term outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 2008;35:703-6. (Pubitemid 351500070)
10. Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina 2007;27:399-413. (Pubitemid 46624278)
11. Richards JC, Tay-Kearney ML, Murray K, Manners P. Infliximab for juvenile idiopathic arthritis associated uveitis. Clin Exp Ophthalmol 2005;35:461-8. (Pubitemid 44056400)
12. Tynjala P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V. Adalimumab in juvenile idiopathic arthritis associated chronic anterior uveitis. Rheumatology 2008;47:339-44. (Pubitemid 351267203)
13. Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007;91:319-24. (Pubitemid 46586527)
14. Vasquez-Cobian LB, Flynn T, Lehman TJ. Adalimumab therapy for childhood uveitis. J Pediatr 2006;149:572-5. (Pubitemid 44468085)
15. Simonini G, Taddio A, Cattalini M, Caputo R, De Libero C, Naviglio S, et al. Prevention of flare recurrences in childhood refractory chronic uveitis: An open-label comparative study of adalimumab versus infliximab. Arthritis Care Res 2011;63:612-8.
16. Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002;85:61-75.
17. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403-20. (Pubitemid 350202485)
18. Diaz-Llopis M, Garcia-Delpech S, Salom D, Udaondo P, Hernández- Garfella M, Bosch-Morell F, et al. Adalimumab therapy for refractory uveitis: A pilot study. J Ocul Pharmacol Ther 2008;24:351-61. (Pubitemid 351733224)
19. Dhingra N, Morgan J, Dick AD. Switching biologic agents for uveitis. Eye 2009;23:1868-70.
20. Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A. Adalimumab (Humira): A promising monoclonal anti-tumor necrosis factor alpha in ophthalmology. Int Ophthalmol 2011;31:165-73.
21. Trachana M, Pratsidou-Gertsi P, Pardalos G, Kozeis N, Badouraki M, Kanakoudi-Tsakalidou F. Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis. Scand J Rheumatol 2011;40:101-7.
22. Tugal-Tutkun I, Ayranci O, Kasapcopur O, Kir N. Retrospective analysis of children with uveitis treated with infliximab. J AAPOS 2008;12:611-3.
23. Duncan J, Heath J, Baildam E, Cleary G, Beresford M, McCann LJ. Autoantibody testing for children on biologic therapies for rheumatologic conditions: Result of audit [abstract]. Pediatr Rheum 2011;9:81-2.